• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床危险因素列线图模型对直接经皮冠状动脉介入治疗后缺血再灌注损伤的预测价值。

The predictive value of the nomogram model of clinical risk factors for ischemia-reperfusion injury after primary percutaneous coronary intervention.

机构信息

Department of Cardiology, Beijing Shijitan Hospital, Capital Medical University, No. 10 Tieyi Road, Haidian District, Beijing, 100038, China.

出版信息

Sci Rep. 2023 Mar 28;13(1):5084. doi: 10.1038/s41598-023-32222-2.

DOI:10.1038/s41598-023-32222-2
PMID:36977721
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10050001/
Abstract

Ischemia-reperfusion injury is a risk factor for poor clinical prognosis in patients with ST-segment elevation myocardial infarction (STEMI). However, due to the inability to predict the risk of its occurrence early, the effect of intervention measures is still being determined. This study intends to construct a nomogram prediction model and evaluate its value in predicting the risk of ischemia-reperfusion injury (IRI) after primary percutaneous coronary intervention (PCI). The clinical admission data of 386 STEMI patients who underwent primary PCI were retrospectively analyzed. According to the degree of ST-segment resolution (STR), the patients were divided into the STR < 70% group (n = 197) and the STR > 70 group (n = 187). The least absolute shrinkage and selection operator (LASSO) regression method was used to screen out IRI's admission-related clinical risk factors. The R language software was used to construct and verify the IRI nomogram prediction model based on the above indicators. The peak troponin level and the incidence of in-hospital death in the STR < 70% group were significantly higher than those in the STR > 70% group (p < 0.01), and the left ventricular ejection fraction was significantly lower than that in the STR > 70% group (p < 0.01). Combined with the results of LASSO regression and receiver operating characteristic curve comparison analysis, we constructed a six-dimensional nomogram predictive model: hypertension, anterior myocardial infarction, culprit vessel, proximal occlusion, C-reactive protein (CRP) > 3.85 mg/L, white blood cell count, neutrophil cell count, and lymphocyte count. The area under the nomogram's receiver operating characteristic (ROC) curve was 0.779. The clinical decision curve found that the nomogram had good clinical applicability when the occurrence probability of IRI was between 0.23 and 0.95. The nomogram prediction model constructed based on six clinical factors at admission has good prediction efficiency and clinical applicability regarding the risk of IRI after primary PCI in patients with acute myocardial infarction.

摘要

缺血再灌注损伤是 ST 段抬高型心肌梗死(STEMI)患者临床预后不良的危险因素。然而,由于无法早期预测其发生的风险,干预措施的效果仍在确定之中。本研究旨在构建列线图预测模型,并评估其预测急性心肌梗死患者直接经皮冠状动脉介入治疗(PCI)后缺血再灌注损伤(IRI)风险的价值。回顾性分析了 386 例接受直接 PCI 的 STEMI 患者的临床入院数据。根据 ST 段回落程度(STR),将患者分为 STR<70%组(n=197)和 STR>70%组(n=187)。采用最小绝对收缩和选择算子(LASSO)回归方法筛选出与 IRI 相关的入院临床危险因素。使用 R 语言软件构建并验证了基于上述指标的 IRI 列线图预测模型。STR<70%组的峰值肌钙蛋白水平和院内死亡发生率明显高于 STR>70%组(p<0.01),左心室射血分数明显低于 STR>70%组(p<0.01)。结合 LASSO 回归和受试者工作特征曲线比较分析的结果,构建了一个六维列线图预测模型:高血压、前壁心肌梗死、罪犯血管、近端闭塞、C 反应蛋白(CRP)>3.85mg/L、白细胞计数、中性粒细胞计数和淋巴细胞计数。列线图的受试者工作特征(ROC)曲线下面积为 0.779。临床决策曲线发现,当 IRI 发生概率在 0.23 至 0.95 之间时,列线图具有良好的临床适用性。基于入院时 6 个临床因素构建的列线图预测模型对急性心肌梗死患者直接 PCI 后 IRI 风险具有良好的预测效率和临床适用性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b70/10050001/699a29bb8ef9/41598_2023_32222_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b70/10050001/db3428eb1fe6/41598_2023_32222_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b70/10050001/49fdc4d3c469/41598_2023_32222_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b70/10050001/82c7ddab4dd8/41598_2023_32222_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b70/10050001/e58dc1fa1312/41598_2023_32222_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b70/10050001/d10325342c7c/41598_2023_32222_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b70/10050001/970a832021fb/41598_2023_32222_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b70/10050001/699a29bb8ef9/41598_2023_32222_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b70/10050001/db3428eb1fe6/41598_2023_32222_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b70/10050001/49fdc4d3c469/41598_2023_32222_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b70/10050001/82c7ddab4dd8/41598_2023_32222_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b70/10050001/e58dc1fa1312/41598_2023_32222_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b70/10050001/d10325342c7c/41598_2023_32222_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b70/10050001/970a832021fb/41598_2023_32222_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b70/10050001/699a29bb8ef9/41598_2023_32222_Fig7_HTML.jpg

相似文献

1
The predictive value of the nomogram model of clinical risk factors for ischemia-reperfusion injury after primary percutaneous coronary intervention.临床危险因素列线图模型对直接经皮冠状动脉介入治疗后缺血再灌注损伤的预测价值。
Sci Rep. 2023 Mar 28;13(1):5084. doi: 10.1038/s41598-023-32222-2.
2
Construction and evaluation of nomogram model for individualized prediction of risk of major adverse cardiovascular events during hospitalization after percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction.急性ST段抬高型心肌梗死患者经皮冠状动脉介入治疗后住院期间主要不良心血管事件风险个体化预测列线图模型的构建与评估
Front Cardiovasc Med. 2022 Dec 21;9:1050785. doi: 10.3389/fcvm.2022.1050785. eCollection 2022.
3
Establishment and validation of a risk model for prediction of in-hospital mortality in patients with acute ST-elevation myocardial infarction after primary PCI.建立并验证一个预测直接经皮冠状动脉介入治疗(PCI)后急性 ST 段抬高型心肌梗死患者院内死亡率的风险模型。
BMC Cardiovasc Disord. 2020 Dec 9;20(1):513. doi: 10.1186/s12872-020-01804-7.
4
A Predictive Model for Contrast-Induced Acute Kidney Injury After Percutaneous Coronary Intervention in Elderly Patients with ST-Segment Elevation Myocardial Infarction.预测老年 ST 段抬高型心肌梗死患者经皮冠状动脉介入治疗后对比剂诱导急性肾损伤的模型。
Clin Interv Aging. 2023 Mar 22;18:453-465. doi: 10.2147/CIA.S402408. eCollection 2023.
5
[Comparison of the predictive value of the modified CADILLAC, GRACE and TIMI risk scores for the risk of short-term death in patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention].[改良CADILLAC、GRACE和TIMI风险评分对急性ST段抬高型心肌梗死患者经皮冠状动脉介入治疗后短期死亡风险的预测价值比较]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023 Mar;35(3):299-304. doi: 10.3760/cma.j.cn121430-20220727-00696.
6
[Association between CD137 and ischemia-reperfusion injury in patients with acute ST-segment elevation myocardial infarction].[急性ST段抬高型心肌梗死患者CD137与缺血再灌注损伤的关系]
Zhonghua Xin Xue Guan Bing Za Zhi. 2021 Dec 24;49(12):1198-1205. doi: 10.3760/cma.j.cn112148-20210517-00425.
7
Development and validation of a prognostic model for predicting post-discharge mortality risk in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PPCI).ST 段抬高型心肌梗死(STEMI)患者行直接经皮冠状动脉介入治疗(PPCI)后出院后死亡风险预测的预后模型的建立与验证。
J Cardiothorac Surg. 2024 Mar 30;19(1):163. doi: 10.1186/s13019-024-02665-3.
8
Development of a nomogram for the prediction of in-hospital mortality in patients with acute ST-elevation myocardial infarction after primary percutaneous coronary intervention: a multicentre, retrospective, observational study in Hebei province, China.基于中国河北省多中心、回顾性、观察性研究的结果,制定了一种预测接受直接经皮冠状动脉介入治疗的急性 ST 段抬高型心肌梗死患者住院期间死亡率的列线图。
BMJ Open. 2022 Feb 2;12(2):e056101. doi: 10.1136/bmjopen-2021-056101.
9
Development and Validation of a Risk Nomogram Model for Predicting Contrast-Induced Acute Kidney Injury in Patients with Non-ST-Elevation Acute Coronary Syndrome Undergoing Primary Percutaneous Coronary Intervention.开发和验证预测行直接经皮冠状动脉介入治疗的非 ST 段抬高型急性冠状动脉综合征患者对比剂诱导急性肾损伤风险列线图模型。
Clin Interv Aging. 2022 Jan 26;17:65-77. doi: 10.2147/CIA.S349159. eCollection 2022.
10
Evaluation of a nomogram model for predicting in-hospital mortality risk in patients with acute ST-elevation myocardial infarction and acute heart failure post-PCI.评估用于预测 PCI 术后急性 ST 段抬高型心肌梗死合并急性心力衰竭患者住院死亡风险的列线图模型。
Scand Cardiovasc J. 2024 Dec;58(1):2387001. doi: 10.1080/14017431.2024.2387001. Epub 2024 Aug 2.

引用本文的文献

1
Predictive value of an early comprehensive assessment model for refractory mycoplasma pneumoniae pneumonia and internal validation.难治性支原体肺炎早期综合评估模型的预测价值及内部验证
BMC Infect Dis. 2025 May 24;25(1):744. doi: 10.1186/s12879-025-11133-9.
2
Ischemic preconditioning modulates the DNA methylation process of the rat heart to provide tolerance to withstand ischemia reperfusion injury and its associated mitochondrial dysfunction.缺血预处理可调节大鼠心脏的DNA甲基化过程,以提供耐受性来抵御缺血再灌注损伤及其相关的线粒体功能障碍。
3 Biotech. 2024 Apr;14(4):121. doi: 10.1007/s13205-024-03965-0. Epub 2024 Mar 26.
3

本文引用的文献

1
REPERFUSION INJURY IN ACUTE PERIOD OF MYOCARDIAL INFARCTION - WAYS OF PREVENTION AND CORRECTION.心肌梗死急性期再灌注损伤-预防与纠正的途径。
Wiad Lek. 2022;75(10):2514-2518. doi: 10.36740/WLek202210137.
2
Elevated platelet-leukocyte complexes are associated with, but dispensable for myocardial ischemia-reperfusion injury.血小板-白细胞复合物升高与心肌缺血再灌注损伤有关,但不是必需的。
Basic Res Cardiol. 2022 Nov 16;117(1):61. doi: 10.1007/s00395-022-00970-3.
3
Treatment strategies of acute myocardial infarction: updates on revascularization, pharmacological therapy, and beyond.
Optimization strategy for the early timing of bronchoalveolar lavage treatment for children with severe mycoplasma pneumoniae pneumonia.
严重肺炎支原体肺炎患儿支气管肺泡灌洗治疗时机的优化策略。
BMC Infect Dis. 2023 Oct 5;23(1):661. doi: 10.1186/s12879-023-08619-9.
急性心肌梗死的治疗策略:再血管化、药物治疗及其他方面的最新进展。
J Cardiol. 2023 Feb;81(2):168-178. doi: 10.1016/j.jjcc.2022.07.003. Epub 2022 Jul 23.
4
Outcomes in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention or pharmacoinvasive strategy in a Latin American country.在一个拉丁美洲国家,采用直接经皮冠状动脉介入治疗或药物侵入性策略治疗 ST 段抬高型心肌梗死的结果。
BMC Cardiovasc Disord. 2022 Jun 29;22(1):296. doi: 10.1186/s12872-022-02730-6.
5
Intramyocardial Hemorrhage and the "Wave Front" of Reperfusion Injury Compromising Myocardial Salvage.心肌内出血与再灌注损伤的“波阵面”危及心肌挽救。
J Am Coll Cardiol. 2022 Jan 4;79(1):35-48. doi: 10.1016/j.jacc.2021.10.034.
6
Coronary Reperfusion in Acute Myocardial Infarction: Trying the Optimal. Executing the Possible.急性心肌梗死中的冠状动脉再灌注:探寻最优方案,践行可行之策。
Arq Bras Cardiol. 2021 Jul;117(1):130-131. doi: 10.36660/abc.20210500.
7
Hypothermia for Reduction of Myocardial Reperfusion Injury in Acute Myocardial Infarction: Closing the Translational Gap.低温治疗减少急性心肌梗死心肌再灌注损伤:缩小转化差距。
Circ Cardiovasc Interv. 2021 Aug;14(8):e010326. doi: 10.1161/CIRCINTERVENTIONS.120.010326. Epub 2021 Jul 16.
8
Hydroxysafflor Yellow A Ameliorates Myocardial Ischemia/Reperfusion Injury by Suppressing Calcium Overload and Apoptosis.羟基红花黄色素 A 通过抑制钙超载和细胞凋亡减轻心肌缺血/再灌注损伤。
Oxid Med Cell Longev. 2021 May 21;2021:6643615. doi: 10.1155/2021/6643615. eCollection 2021.
9
Myocardial ischaemia-reperfusion injury and cardioprotection in perspective.心肌缺血再灌注损伤及心肌保护的展望。
Nat Rev Cardiol. 2020 Dec;17(12):773-789. doi: 10.1038/s41569-020-0403-y. Epub 2020 Jul 3.
10
Pathophysiology and diagnosis of coronary microvascular dysfunction in ST-elevation myocardial infarction.ST 段抬高型心肌梗死中冠状动脉微血管功能障碍的病理生理学和诊断。
Cardiovasc Res. 2020 Mar 1;116(4):787-805. doi: 10.1093/cvr/cvz301.